Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Clinical trial NCT00343863 · COMPLETED

Trial details

NCT number: NCT00343863
Sponsor: University of Washington
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Male Breast Cancer Nausea and Vomiting Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer

Start date: 2006-01-01
Primary completion: 2010-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.